Quality by Design Approach for Understanding the Critical Quality Attributes of Cyclosporine Ophthalmic Emulsion

被引:35
|
作者
Rahman, Ziyaur [1 ]
Xu, Xiaoming [1 ]
Katragadda, Usha [1 ]
Krishnaiah, Yellela S. R. [1 ]
Yu, Lawrence [2 ]
Khan, Mansoor A. [1 ]
机构
[1] US FDA, Div Prod Qual Res, Off Testing & Res, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
[2] US FDA, Off Gener Drugs, Ctr Drug Evaluat & Res, Rockville, MD 20852 USA
关键词
quality by design; cyclosporine; microemulsion; ophthalmic; critical quality attributes droplet size; zeta potential; viscosity; diffusion; DRY EYE DISEASE; OCULAR DISTRIBUTION; PLGA NANOPARTICLES; PARTICLE-SIZE; TEMPERATURE; STABILITY; PENETRATION; MICELLES; EFFICACY; CARRIERS;
D O I
10.1021/mp400484g
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Restasis is an ophthalmic cyclosporine emulsion used for the treatment of dry eye syndrome. There are no generic products for this product, probably because of the limitations on establishing in vivo bioequivalence methods and lack of alternative in vitro bioequivalence testing methods. The present investigation was carried out to understand and identify the appropriate in vitro methods that. can discriminate the effect of formulation and process variables on critical quality attributes (CQA) of cyclosporine microemulsion formulations having the same qualitative (Q1) and quantitative (Q2) composition as that of Restasis. Quality by design (QbD) approach was used to understand the effect of formulation and process variables on critical quality attributes (CQA) of cyclosporine microemulsion. The formulation variables chosen were mixing order method, phase volume ratio, and pH adjustment method, while the process variables were temperature of primary and raw emulsion formation, microfluidizer pressure, and number of pressure cycles. The responses selected were particle size, turbidity, zeta potential, viscosity, osmolality, surface tension, contact angle, pH, and drug diffusion. The selected independent variables showed statistically significant (p < 0.05) effect on droplet size, zeta potential, viscosity, turbidity, and osmolality. However, the surface tension, contact angle, pH, and drug diffusion were not significantly affected by independent variables. In summary, in vitro methods can detect formulation and manufacturing changes and would thus be important for quality control or sameness of cyclosporine ophthalmic products.
引用
收藏
页码:787 / 799
页数:13
相关论文
共 50 条
  • [1] Comment on "Quality by Design Approach for Understanding the Critical Quality Attributes of Cyclosporine Ophthalmic Emulsion"
    Gore, Anuradha
    Attar, Mayssa
    Pujara, Chetan
    Neervannan, Sesha
    [J]. MOLECULAR PHARMACEUTICS, 2014, 11 (07) : 2490 - 2492
  • [2] A Quality By Design Approach For Longitudinal Quality Attributes
    Lebrun, Pierre
    Giacoletti, Katherine
    Scherder, Tara
    Rozet, Eric
    Boulanger, Bruno
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2015, 25 (02) : 247 - 259
  • [3] A Robust Dual-mode MPC Approach to Ensuring Critical Quality Attributes in Quality-by-Design
    Harinath, Eranda
    Foguth, Lucas C.
    Braatz, Richard D.
    [J]. 2016 AMERICAN CONTROL CONFERENCE (ACC), 2016, : 2041 - 2046
  • [4] Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery
    Peltonen, Leena
    Strachan, Clare
    [J]. MOLECULES, 2015, 20 (12): : 22286 - 22300
  • [5] Quality by Design for Herbal Drugs: a Feedforward Control Strategy and an Approach to Define the Acceptable Ranges of Critical Quality Attributes
    Yan, Binjun
    Li, Yao
    Guo, Zhengtai
    Qu, Haibin
    [J]. PHYTOCHEMICAL ANALYSIS, 2014, 25 (01) : 59 - 65
  • [6] Determination of critical quality attributes for monoclonal antibodies using quality by design principles
    Alt, Nadja
    Zhang, Taylor Y.
    Motchnik, Paul
    Taticek, Ron
    Quarmby, Valerie
    Schlothauer, Tilman
    Beck, Hermann
    Emrich, Thomas
    Harris, Reed J.
    [J]. BIOLOGICALS, 2016, 44 (05) : 291 - 305
  • [7] Quality by Design in Action 1: Controlling Critical Quality Attributes of an Active Pharmaceutical Ingredient
    Mohammed, Abdul Qayum
    Sunkari, Phani Kiran
    Srinivas, P.
    Roy, Amrendra Kumar
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2015, 19 (11) : 1634 - 1644
  • [8] A design space exploration for control of Critical Quality Attributes of mAb
    Bhatia, Hemlata
    Read, Erik
    Agarabi, Cyrus
    Brorson, Kurt
    Lute, Scott
    Yoon, Seongkyu
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 512 (01) : 242 - 252
  • [9] A Bayesian Approach to Setting the Release Limits for Critical Quality Attributes
    Yu, Binbing
    Zeng, Lingmin
    Yang, Harry
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2018, 10 (03): : 158 - 165
  • [10] A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation
    Aksu, Buket
    Paradkar, Anant
    de Matas, Marcel
    Ozer, Ozgen
    Guneri, Tamer
    York, Peter
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (01) : 236 - 245